R&D channel feed – Endpoints News

R&D channel feed

Amgen shelves early-stage bispecific T cell engager

11 months ago

Six big R&D questions for Pfizer as science chief Dolsten exits

11 months ago

UniQure trumpets mid-stage data for Huntington's disease gene therapy

11 months ago

Chinese drugmakers still lag in R&D depth despite outpacing Europeans in new launches

11 months ago

Lilly bests Novo Nordisk in observational study of GLP-1 drugs

11 months ago

Infections are major cause of non-relapse deaths after CAR-T cell therapy, study shows

11 months ago

HilleVax's stock tumbles after Phase 2b norovirus vaccine fails in infants

11 months ago

Ideaya showcases proof-of-concept data in a boost to synthetic lethality play

11 months ago

With cash expected to run dry, Inventiva ramps up search for funding

11 months ago

Roche’s TIGIT drug tiragolumab flunks another Phase 3 lung cancer test

11 months ago

Apollomics plans to lay off staff, narrow focus for lung cancer trial

11 months ago

Moderna wins $176M BARDA award to finance bird flu work

11 months ago

Following a pivotal trial fail and layoffs, Ovid finds itself in a familiar spot

11 months ago

J&J and Legend say Carvykti improved survival in earlier-line multiple myeloma

11 months ago

Four key weight loss readouts to watch at #EASD24

11 months ago

Cartesian clears an autoimmune CAR-T trial, starts another Phase 2 and raises $130M

11 months ago

Corrected: Boehringer Ingelheim, Gubra put a second candidate into the obesity race

11 months ago

Aerovate plans to lay off nearly all employees after trial failure

11 months ago

Eisai takes over development of ADC after Bristol Myers ends $650M collaboration

11 months ago

Dianthus teases preclinical data for autoimmune drug as it starts clinical trials

11 months ago

EMA's CHMP recommends 10 new drugs as Pierre Fabre overactive bladder med wins approval

11 months ago

J&J details Phase 3 success of autoimmune disease drug, touting broader range than argenx’s Vyvgart

11 months ago

Lykos takes another hit as ICER lays out 'insufficient' evidence for MDMA-based treatment

11 months ago

To tackle a deadly brain disease, scientists devise small but charming epigenetic editing tool

11 months ago

First page Previous page 37 38 394041 42 43 Next page Last page